September 30, 2006
Professor John Mattick, Foundation Professor of Molecular Biology at the University of Queensland, 9/29/06
Professor John Mattick is the Foundation Professor of Molecular Biology and the Director of the Institute for Molecular Bioscience at the University of Queensland. Professor Mattick’s research interest is in the role of noncoding RNA in the evolution and development of complex organisms. He has published over 150 scientific papers, most recently "The hidden genetic program of complex organisms" (Scientific American 291(4):60-67), “RNA regulation: a new genetics?” (Nature Reviews Genetics 5:316-323), and "Non-coding RNA" (Human Molecular Genetics 15: R17-R29).
Professor Mattick has developed a new theory of the structure of genetic information in higher organisms, which may explain the purpose of so-called junk DNA in the human genome as a hidden information system that directs human development.
The University of Queensland's Institute for Molecular Bioscience (IMB) is one of Australia's leading research institutions and a major center for molecular bioscience research. IMB links leading-edge genomic discovery and bioinformatic facilities with state-of-the-art research to better understand human and animal biology, and to develop new pharmaceuticals, diagnostics, nanotechnologies, and disease therapies.
Dr. Alan Paau, Assistant Vice Chancellor, Technology Transfer and Intellectual Property Services, and Dr. Arthur B. Ellis, Vice Chancellor for Research, University of California, San Diego, 9/29/06
Prior to joining UC San Diego as Assistant Vice Chancellor, Technology Transfer and Intellectual Property Services, Dr. Alan Paau was Executive Director of the Iowa State University Research Foundation, Inc. and Director of Intellectual Property & Technology Transfer at Iowa State University. Previously, he was Associate Director of the Biotechnology Center at the Ohio State University with responsibilities in research administration, technology management, and industry liaison. Dr. Paau held faculty appointments while at Iowa State University in the departments of Preventive Medicine, Immunology & Microbiology, and Genetics & Zoology, and at the Ohio State University in the departments of Microbiology, and Plant Pathology.
Dr. Paau is the inventor to eight U.S. patents and has contributed 30 peer-reviewed research articles to scientific journals and six invited reviews/chapters to technical books. As a director of intellectual property and a licensing executive, he supervised the execution of over 800 licenses and option agreements and the formation of over 90 startup companies using university innovations.
Dr. Arthus Ellis, who joined UC San Diego on September 1, 2006, comes from the National Science Foundation, where he served as the Director for the Division of Chemistry. He is an internationally recognized chemist and widely known for his leadership in advancing the mission of research in the University to create and communicate new knowledge. Dr. Ellis holds Ph.D. and B.S. degrees in chemistry from MIT and Caltech, respectively.
Dr. Ellis has served as Meloche-Bascom Professor of Chemistry and as the Chair of the Graduate Materials Science Program at the University of Wisconsin at Madison. Among his many awards are Guggenheim and Sloan Fellowships, the National Science Foundation Director’s Meritorious Service Award and the NSF’s Distinguished Teaching Scholar Award. Dr. Ellis and his co-workers have published more than 200 research papers in leading scientific journals and obtained nine patents.
Dr. Alan Zelicoff, author of MICROBE: Are We Ready For the Next Plague?, 9/29/06
Dr. Alan Zelicoff is a physician (board certified in Internal Medicine 1992, clinical fellowship in Rheumatology, 1983) and physicist (AB Princeton, 1975), who has had a varied career including clinical practice, teaching, and operations research. In the latter roles, he was Senior Scientist in the Center for National Security and Arms Control at Sandia National Laboratories from 1989–2003. Dr. Zelicoff’s interests include risk and hazard analysis in hospital systems and office-based practice, and in technologies for improving the responsiveness of public health offices and countering biological weapons terrorism.
Dr. Zelicoff has traveled extensively in countries of the former Soviet Union and has led joint research projects in epidemiology of infectious disease, while establishing Internet access at Russian and Kazak biological laboratories. The result of this activity is a real-time clinician-based disease surveillance and reporting system called the Syndrome Reporting Information System (SYRIS) which is now being used by public health officials responsible for monitoring the health of more than 1 million people in Texas and countless agricultural animals and wildlife as well. The State of California legislature has recently passed a bill to test this approach in order to modernize disease surveillance in the state.
Dr. Zelicoff’s latest book is MICROBE: Are We Ready for the Next Plague?, published by AMACOM Books. His next book, scheduled for release in 2007 is entitled Doctor, Don’t Just Do Something, Stand There. He is the author of numerous textbook chapters and articles, and is a frequent contributor to Op-Ed pages in the Washington Post and other newspapers.
September 26, 2006
Dr. John Fourkas, Millard Alexander Professor of Chemistry, University of Maryland, 6/21/06
Dr. John Fourkas is the Millard Alexander Professor of Chemistry at the University of Maryland, College Park, and is also a member of the Institute for Physical Science and Technology at UMD and the Maryland Center for Integrated Nano Science and Engineering. His training was in the application of lasers to understand chemistry in liquids. Professor Fourkas continues to work in this field, and his research has expanded to include applications of lasers in areas such as micro- and nanotechnology, microscopy, and high-density data storage. A major focus of his current research efforts is the use of lasers to fabricate three-dimensional micromachines.
Professor Fourkas has published more than 100 papers and has co-edited three books. His research has been covered in venues that include Discover, Popular Science, and New Scientist. He is a Senior Editor of the Journal of Physical Chemistry.
Professor Fourkas is a Fellow of the American Physical Society and the American Association for the Advancement of Science. His accomplishments in research and education have been recognized with awards that include Beckman Young Investigator, Research Corporation Cottrell Scholar, Sloan Research Fellow, and Camille Dreyfus Teacher-Scholar.
September 23, 2006
Dr. Eric Neumann, Co-Chair, W3C Healthcare and Life Sciences, and Senior Director of Product Strategy, Teranode Corporation, Part One, 9/22/06
Dr. Eric Neumann comes to Teranode Corporation with nearly 20 years of experience in bioinformatics and semantic technologies development. He was previously responsible for negotiating key partnerships with IT vendors and pharmaceutical companies, as well as developing knowledge management and Semantic Web standards for various life sciences initiatives. Prior to joining Teranode, Dr. Neumann held executive positions and developed semantic technologies for Sanofi-Aventis Pharmaceuticals, Beyond Genomics, NetGenics, and Bolt, Beranek, and Newman.
Dr. Neumann is Co-Chair, W3C Healthcare and Life Sciences.
Dr. Eric Neumann, Co-Chair, W3C Healthcare and Life Sciences, and Senior Director of Product Strategy, Teranode Corporation, Part Two, 9/22/06
Dr. Michael Wong, Assistant Professor of Chemical Engineering and Assistant Professor of Chemistry, Rice University, 9/22/06
Dr. Michael S. Wong is Assistant Professor of both Chemical Engineering and Chemistry at Rice University in Houston, TX. His research in nanostructured materials is at the cutting edge of chemistry and is extending the traditional boundaries of both chemical engineering and materials science. He has used nanoparticles to develop innovative new catalysts for the chemical industry, a new class of microcapsule for biomedical applications, and palladium-coated gold nanoparticles for the environmental remediation of water contaminated by chlorinated compounds like TCE.
Dr. Wong's research has been featured in Scientific American, New Scientist, and Science News. Technology Review magazine recently named him to its coveted TR35 list — a compilation of the world's top 35 innovators under the age of 35.
Dr. Wong earned his bachelor's degree in chemical engineering from Caltech, and his master's and doctoral degrees from MIT. He did his postdoctoral research at the University of California, Santa Barbara, and joined Rice's faculty in 2001.